Caveolae: Mining little caves for new cancer targets

被引:224
作者
Carver, LA [1 ]
Schnitzer, JE [1 ]
机构
[1] Sidney Kimmel Canc Ctr, Div Vasc Biol & Angiogenesis, San Diego, CA 92121 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nrc1146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Caveolae exist at cell surfaces as caveolin-coated invaginations that perform transport and signalling functions influencing cell growth, apoptosis, angiogenesis and transvascular exchange. Caveolin could constitute a key switch in tumour development through its function as a tumour suppressor and as a promoter of metastasis, chemoresistance and survival. Targeting of drugs and gene vectors to tissue-specific proteins in caveolae allows selective delivery into vascular endothelial cells in vivo and might even improve direct access to solid-tumour cells. Therefore, caveolae seem to be rich in potential targets for cancer imaging and therapeutics.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 134 条
[21]   Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3) - Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/731) [J].
Engelman, JA ;
Zhang, XL ;
Galbiati, F ;
Lisanti, MP .
FEBS LETTERS, 1998, 429 (03) :330-336
[22]   Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo -: Implications for human breast cancer [J].
Engelman, JA ;
Lee, RJ ;
Karnezis, A ;
Bearss, DJ ;
Webster, M ;
Siegel, P ;
Muller, WJ ;
Windle, JJ ;
Pestell, RG ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20448-20455
[23]   Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].
Engelman, JA ;
Wykoff, CC ;
Yasuhara, S ;
Song, KS ;
Okamoto, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381
[24]   Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin [J].
Feng, D ;
Nagy, JA ;
Hipp, J ;
Dvorak, HF ;
Dvorak, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :1981-1986
[25]   Pathways of macromolecular extravasation across microvascular endothelium in response to VPF VEGF and other vasoactive mediators [J].
Feng, D ;
Nagy, JA ;
Pyne, K ;
Hammel, I ;
Dvorak, HF ;
Dvorak, AM .
MICROCIRCULATION, 1999, 6 (01) :23-44
[26]  
Feng YY, 1999, INVEST OPHTH VIS SCI, V40, P157
[27]   Endothelial nitric oxide synthase targeting to caveolae - Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells [J].
Feron, O ;
Belhassen, L ;
Kobzik, L ;
Smith, TW ;
Kelly, RA ;
Michel, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22810-22814
[28]   VEGF and the quest for tumour angiogenesis factors [J].
Ferrara, N .
NATURE REVIEWS CANCER, 2002, 2 (10) :795-803
[29]   Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells [J].
Fiucci, G ;
Ravid, D ;
Reich, R ;
Liscovitch, M .
ONCOGENE, 2002, 21 (15) :2365-2375
[30]   INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA [J].
FOLKMAN, J ;
WATSON, K ;
INGBER, D ;
HANAHAN, D .
NATURE, 1989, 339 (6219) :58-61